Skip to main content
Erschienen in: Journal of Artificial Organs 4/2017

11.09.2017 | Original Article

Efficacy of hemofiltration with PEPA membrane for IL-6 removal in a rat sepsis model

Erschienen in: Journal of Artificial Organs | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Recently, intensive care physicians have focused on continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of sepsis. We aimed to establish extracorporeal circulation in a rat sepsis model to evaluate the cytokine removal properties of mini-modules using two types of membrane materials. Rats were divided into polyester polymer alloy (PEPA) and cellulose triacetate (CTA) groups as membrane materials of mini-modules. One hour after 0.1 mg/kg of lipopolysaccharide administration, continuous hemofiltration (CHF) was started in each group. Plasma interleukin-6 (IL-6), an important mediator of sepsis, was measured over time during hemofiltration. The peak IL-6 concentration in PEPA group was approximately 13,000 pg/mL, in comparison to approximately 31,000 pg/mL in CTA group. IL-6 clearance in PEPA group was much more than CTA group. Since IL-6 was not detected in the filtrate in PEPA group, it was considered that IL-6 was adsorbed to the membrane. In conclusion, our results suggest that CHF with PEPA hemofilter can be suitable for removing IL-6 from the blood stream efficiently.
Literatur
1.
2.
Zurück zum Zitat Ronco C, Bonello M, Bordoni V, Ricci Z, D’Intini V, Bellomo R, Levin NW. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22:164–74.CrossRefPubMed Ronco C, Bonello M, Bordoni V, Ricci Z, D’Intini V, Bellomo R, Levin NW. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22:164–74.CrossRefPubMed
3.
Zurück zum Zitat Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.CrossRefPubMedPubMedCentral Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis. Blood Purif. 2012;34:164–70.CrossRefPubMed Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis. Blood Purif. 2012;34:164–70.CrossRefPubMed
5.
Zurück zum Zitat Igoshi T, Tomisawa N, Hori Y, Jinbo Y. Polyester polymer alloy as a high-performance membrane. Contrib Nephrol.2011;173:148–55.CrossRefPubMed Igoshi T, Tomisawa N, Hori Y, Jinbo Y. Polyester polymer alloy as a high-performance membrane. Contrib Nephrol.2011;173:148–55.CrossRefPubMed
6.
Zurück zum Zitat Thomas JR, Harlan JM, Rice CL, Winn RK. Role of leukocyte CD11/CD18 complex in endotoxic and septic shock in rabbits. J Appl Physiol. 1992;73:1510–16.PubMed Thomas JR, Harlan JM, Rice CL, Winn RK. Role of leukocyte CD11/CD18 complex in endotoxic and septic shock in rabbits. J Appl Physiol. 1992;73:1510–16.PubMed
7.
Zurück zum Zitat Smedegard G, Cui LX, Hugli TE. Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol. 1989;135:489–97.PubMedPubMedCentral Smedegard G, Cui LX, Hugli TE. Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol. 1989;135:489–97.PubMedPubMedCentral
8.
Zurück zum Zitat Von Allmen D, Hasselgren PO, Fisxher JE. Hepatic protein synthesis in a modified septic rat model. J Surg Res. 1990;48:476–80.CrossRef Von Allmen D, Hasselgren PO, Fisxher JE. Hepatic protein synthesis in a modified septic rat model. J Surg Res. 1990;48:476–80.CrossRef
9.
Zurück zum Zitat Lonergan JM, Orlowski JP, Sato T, McHugh MJ. Extracorpotreal endotoxin removal in a canine model of septic shock. ASAIO J. 1994;40:M654–7.CrossRefPubMed Lonergan JM, Orlowski JP, Sato T, McHugh MJ. Extracorpotreal endotoxin removal in a canine model of septic shock. ASAIO J. 1994;40:M654–7.CrossRefPubMed
10.
Zurück zum Zitat Iba T, Nagaoka I, Yamada A, Nagayama M, Miki T. Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model. Int J Med Sci.2014;11:255–61.CrossRefPubMedPubMedCentral Iba T, Nagaoka I, Yamada A, Nagayama M, Miki T. Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model. Int J Med Sci.2014;11:255–61.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Rimmelé T, Wey PF, Bernard N, Monchi M, Semenzato N, Benatir F, Boselli E, Etienne J, Goudable J, Chassard D, Bricca G, Allaouchiche B. Hemofiltration with the cascade system in an experimental porcine model of septic shock. Ther Apher Dial. 2009;13:63–70.CrossRefPubMed Rimmelé T, Wey PF, Bernard N, Monchi M, Semenzato N, Benatir F, Boselli E, Etienne J, Goudable J, Chassard D, Bricca G, Allaouchiche B. Hemofiltration with the cascade system in an experimental porcine model of septic shock. Ther Apher Dial. 2009;13:63–70.CrossRefPubMed
12.
Zurück zum Zitat Sauer M, Altrichter J, Mencke T, Klöhr S, Thomsen M, Kreutzer HJ, Nöldge-Schomburg G, Mitzner SR. Plasma separation by centrifugation and subsequent plasma filtration: impact on survival in a pig model of sepsis. Ther Apher Dial.2012;16:205–12.CrossRefPubMed Sauer M, Altrichter J, Mencke T, Klöhr S, Thomsen M, Kreutzer HJ, Nöldge-Schomburg G, Mitzner SR. Plasma separation by centrifugation and subsequent plasma filtration: impact on survival in a pig model of sepsis. Ther Apher Dial.2012;16:205–12.CrossRefPubMed
13.
Zurück zum Zitat Sunohara T, Masuda T. Cellulose triacetate as a high-performance membrane. Contrib Nephrol. 2011;173:156–63.CrossRefPubMed Sunohara T, Masuda T. Cellulose triacetate as a high-performance membrane. Contrib Nephrol. 2011;173:156–63.CrossRefPubMed
14.
Zurück zum Zitat Henderson LW. Hemodialysis. Rationale and physical principles. In: Brenner BM, Rector FC, editors. The kidney. 1st ed. Philadelphia: W.B. Saunders; 1976. pp. 1643–71. Henderson LW. Hemodialysis. Rationale and physical principles. In: Brenner BM, Rector FC, editors. The kidney. 1st ed. Philadelphia: W.B. Saunders; 1976. pp. 1643–71.
15.
Zurück zum Zitat Gotch FA. Hemodialysis. Rationale and physical principles. In: Brenner BM, Rector FC, editors. The kidney. 1st ed. Philadelphia: W.B. Saunders; 1976. 1672 – 704. p. Gotch FA. Hemodialysis. Rationale and physical principles. In: Brenner BM, Rector FC, editors. The kidney. 1st ed. Philadelphia: W.B. Saunders; 1976. 1672 – 704. p.
16.
Zurück zum Zitat Delanaye P, Lambermont B, Dogné JM, Dubois B, Ghuysen A, Janssen N, Desaive T, Kolh P, D’Orio V, Krzesinski JM. Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study. Int J Artif Organs. 2006;29:944–8.PubMed Delanaye P, Lambermont B, Dogné JM, Dubois B, Ghuysen A, Janssen N, Desaive T, Kolh P, D’Orio V, Krzesinski JM. Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study. Int J Artif Organs. 2006;29:944–8.PubMed
17.
Zurück zum Zitat Yumoto M, Nishida O, Moriyama K, Shimomura Y, Nakamura T, Kuriyama N, Hara Y, Yamada S. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial. 2011;15:385–93.CrossRefPubMed Yumoto M, Nishida O, Moriyama K, Shimomura Y, Nakamura T, Kuriyama N, Hara Y, Yamada S. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial. 2011;15:385–93.CrossRefPubMed
18.
Zurück zum Zitat Yamashita AC, Tomisawa N. Importance of membrane materials for blood purification devices in critical care. Transfus Apher Sci. 2009;40:23–31.CrossRefPubMed Yamashita AC, Tomisawa N. Importance of membrane materials for blood purification devices in critical care. Transfus Apher Sci. 2009;40:23–31.CrossRefPubMed
19.
Zurück zum Zitat Aoyagi S, Hayama M, Hasegawa U, Sakai K, Tozu M, Hoshi T, Kudo M. Estimation of protein adsorption on dialysis membrane by means of TOF-SIMS imaging. J Memb Sci. 2004;236:91–9.CrossRef Aoyagi S, Hayama M, Hasegawa U, Sakai K, Tozu M, Hoshi T, Kudo M. Estimation of protein adsorption on dialysis membrane by means of TOF-SIMS imaging. J Memb Sci. 2004;236:91–9.CrossRef
20.
Zurück zum Zitat Machiguchi T, Tamura T, Yoshida H. Efficacy of haemodiafiltration treatment with PEPA dialysis membranes in plasma free light chain removal in a patient with primary amyloidosis. Nephrol Dial Transpl. 2002;17:1689–91.CrossRef Machiguchi T, Tamura T, Yoshida H. Efficacy of haemodiafiltration treatment with PEPA dialysis membranes in plasma free light chain removal in a patient with primary amyloidosis. Nephrol Dial Transpl. 2002;17:1689–91.CrossRef
21.
Zurück zum Zitat Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher. 2001;5:306–14.CrossRefPubMed Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher. 2001;5:306–14.CrossRefPubMed
22.
Zurück zum Zitat Shiga H, Hirasawa H, Nishida O, Oda S, Nakamura M, Mashiko K, Matsuda K, Kitamura N, Kikuchi Y, Fuke N. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif. 2014;38:211–8.CrossRefPubMed Shiga H, Hirasawa H, Nishida O, Oda S, Nakamura M, Mashiko K, Matsuda K, Kitamura N, Kikuchi Y, Fuke N. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif. 2014;38:211–8.CrossRefPubMed
Metadaten
Titel
Efficacy of hemofiltration with PEPA membrane for IL-6 removal in a rat sepsis model
Publikationsdatum
11.09.2017
Erschienen in
Journal of Artificial Organs / Ausgabe 4/2017
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-017-0991-4

Weitere Artikel der Ausgabe 4/2017

Journal of Artificial Organs 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.